Jupiter Life Line Hospitals Limited Share Price & Analysis
Price Chart
Fundamentals
Strengths
- Low debt relative to equity (D/E 0.4x)
- Near 52-week low — potential value zone (₹230)
Concerns
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,899 | ₹4.6L Cr | 36.1 | 5.46 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹9,100 | ₹2.4L Cr | 81.1 | 14.42 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹4,857 | ₹1.8L Cr | 82.8 | 19.58 | 27.4 | 15.2 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,650 | ₹1.2L Cr | 59.1 | 13.13 | 21.2 | 17.4 | 0.88 |
| CIPLA Cipla Limited | ₹1,385 | ₹1.1L Cr | 31.3 | 3.25 | 11.6 | 15.5 | 0.01 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,120 | ₹1.1L Cr | 23 | 4.16 | 21.2 | 21.1 | 0.38 |
| LAURUSLABS Laurus Labs Limited | ₹1,840 | ₹99K Cr | 90.9 | 18.74 | 18.3 | 17.8 | 0.46 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
JLHL · as of Mar 2026
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 40.91% | 40.91% | 40.91% | 40.91% | 40.91% | 40.91% |
| FII | 3.96% | 4.17% | 6.06% | 8.84% | 10.04% | 10.04% |
| DII | 13.92% | 14.16% | 13.85% | 13.46% | 15.75% | 15.64% |
| Public | 41.19% | 40.76% | 39.18% | 36.79% | 33.31% | 33.43% |
Corporate Events
To consider and approve the financial results for the period ended Jun 30, 2026
Face Value Split (Sub-Division) - From Rs 10/- Per Share To Rs 2/- Per Share
Interim Dividend - Re 1 Per Share
To consider and approve the financial results for the period ended March 31, 2026
Dividend - Re 1 Per Share
Dividend - Re 1 Per Share
Latest News
All newsJupiter Life Line Hospitals shares no major updates ahead of AGM
*Jupiter Life Line Hospitals shares no major updates ahead of AGM* The company shared the weblink for its AGM notice and annual report. No financial or operational updates were disclosed. Key stakeholders await further details during the upcoming meeting. 📊 *STOCKS:* JUPITER | 🏢 *SECTOR:* Healthcare | #LOWIMPACT #AGM
Jupiter Life Line publishes statutory newspaper notice
*Jupiter Life Line publishes statutory newspaper notice* The company has released a copy of its newspaper publication as part of regulatory compliance. Such filings are routine and do not indicate operational or financial changes. No immediate market-moving information is disclosed. 📊 *STOCKS:* JTLH | 🏢 *SECTOR:* Healthcare | #LOWIMPACT #CorporateFiling
Jupiter Life Line to hold 24th AGM
*Jupiter Life Line to hold 24th AGM* for FY 2025-26. The notice confirms the annual general meeting of shareholders. No major announcements expected beyond routine disclosures. AGMs typically cover dividend proposals and management updates. 📊 *STOCKS:* JUPITER | 🏢 *SECTOR:* Healthcare | #LOWIMPACT #AGM
Jupiter Life Line to hold AGM via video conference
*Jupiter Life Line to hold AGM via video conference*. Jupiter Life Line Hospitals Limited has announced the 24th Annual General Meeting on **July 17, 2026**, to be conducted via video conference. The notice was filed as part of regulatory compliance. No financial or strategic updates were disclosed. 📊 *STOCKS:* JUPITERHOSP | 🏢 *SECTOR:* Healthcare | #LOWIMPACT #AGM
Financials
Quarterly Results
| Metric | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹365 Cr 7.4% | ₹394 Cr 11.6% | ₹353 Cr 4.7% | ₹337 Cr 1.2% | ₹333 Cr 0.6% | ₹335 Cr 15.9% | ₹289 Cr 0.7% | ₹291 Cr |
| Op. Profit | ₹83 Cr 9.8% | ₹92 Cr 17.9% | ₹78 Cr 2.5% | ₹80 Cr 5.3% | ₹76 Cr 2.6% | ₹78 Cr 20.0% | ₹65 Cr 3.2% | ₹63 Cr |
| OPM | 23.0% 0.0% | 23.0% 4.5% | 22.0% 8.3% | 24.0% 4.3% | 23.0% 0.0% | 23.0% 0.0% | 23.0% 4.5% | 22.0% |
| Net Profit | ₹42 Cr 26.3% | ₹57 Cr 29.5% | ₹44 Cr 2.2% | ₹45 Cr 13.5% | ₹52 Cr 0.0% | ₹52 Cr 15.6% | ₹45 Cr 0.0% | ₹45 Cr |
| EPS (₹) | 1.3 25.7% | 1.75 30.6% | 1.34 2.9% | 1.38 13.2% | 1.59 0.6% | 1.58 16.2% | 1.36 80.2% | 6.87 |
Values in ₹ Cr · Source: Screener.in
Annual Profit & Loss
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | ₹1.5K Cr 15.2% | ₹1.3K Cr 21.3% | ₹1.1K Cr 20.2% | ₹893 Cr 21.8% | ₹733 Cr 50.8% | ₹486 Cr 5.0% | ₹463 Cr |
| Expenses | ₹1.2K Cr 15.7% | ₹999 Cr 20.2% | ₹831 Cr 20.3% | ₹691 Cr 19.1% | ₹580 Cr 38.4% | ₹419 Cr 10.6% | ₹379 Cr |
| Op. Profit | ₹343 Cr 13.2% | ₹303 Cr 25.2% | ₹242 Cr 20.4% | ₹201 Cr 31.4% | ₹153 Cr 128.4% | ₹67 Cr 20.2% | ₹84 Cr |
| OPM | 23.0% 0.0% | 23.0% 0.0% | 23.0% 0.0% | 23.0% 9.5% | 21.0% 50.0% | 14.0% 22.2% | 18.0% |
| Other Income | ₹37 Cr 48.0% | ₹25 Cr 13.6% | ₹22 Cr 175.0% | ₹8 Cr 100.0% | ₹4 Cr 0.0% | ₹4 Cr | ₹0 Cr |
| Interest | ₹33 Cr 200.0% | ₹11 Cr 57.7% | ₹26 Cr 38.1% | ₹42 Cr 4.5% | ₹44 Cr 12.8% | ₹39 Cr 50.0% | ₹26 Cr |
| Depreciation | ₹88 Cr 54.4% | ₹57 Cr 35.7% | ₹42 Cr 7.7% | ₹39 Cr 8.3% | ₹36 Cr 16.1% | ₹31 Cr 19.2% | ₹26 Cr |
| PBT | ₹260 Cr 0.4% | ₹261 Cr 33.8% | ₹195 Cr 51.2% | ₹129 Cr 67.5% | ₹77 Cr 3750.0% | ₹2 Cr 93.9% | ₹33 Cr |
| Tax % | 25.0% 3.8% | 26.0% 160.0% | 10.0% 76.7% | 43.0% 26.5% | 34.0% 86.3% | 248.0% 2380.0% | 10.0% |
| Net Profit | ₹194 Cr 0.0% | ₹194 Cr 9.6% | ₹177 Cr 142.5% | ₹73 Cr 43.1% | ₹51 Cr 2650.0% | ₹-2 Cr 106.7% | ₹30 Cr |
| EPS (₹) | 5.92 0.5% | 5.89 9.3% | 5.39 108.9% | 2.58 28.4% | 2.01 2333.3% | -0.09 107.7% | 1.17 |
| Div Payout | 3.0% 0.0% | 3.0% 25.0% | 4.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Values in ₹ Cr · Source: Screener.in
Balance Sheet
| Item | Mar 2026 | Sep 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|---|---|
Liabilities | ||||||||
| Equity Capital | ₹66 Cr 0.0% | ₹66 Cr 0.0% | ₹66 Cr 0.0% | ₹66 Cr 15.8% | ₹57 Cr 11.8% | ₹51 Cr 0.0% | ₹51 Cr 0.0% | ₹51 Cr |
| Reserves | ₹1.5K Cr 6.8% | ₹1.4K Cr 7.3% | ₹1.3K Cr 17.0% | ₹1.1K Cr 257.0% | ₹309 Cr 27.2% | ₹243 Cr 29.3% | ₹188 Cr 1.1% | ₹186 Cr |
| Borrowings | ₹584 Cr 44.9% | ₹403 Cr 2.5% | ₹393 Cr | ₹0 Cr 100.0% | ₹469 Cr 5.3% | ₹495 Cr 16.2% | ₹426 Cr 56.6% | ₹272 Cr |
| Other Liabilities | ₹235 Cr 39.9% | ₹168 Cr 0.0% | ₹168 Cr 50.0% | ₹112 Cr 25.8% | ₹151 Cr 25.8% | ₹120 Cr 3.2% | ₹124 Cr 31.9% | ₹94 Cr |
| Total Liabilities | ₹2.4K Cr 16.8% | ₹2.0K Cr 5.5% | ₹1.9K Cr 49.6% | ₹1.3K Cr 29.9% | ₹986 Cr 8.5% | ₹909 Cr 15.2% | ₹789 Cr 30.8% | ₹603 Cr |
Assets | ||||||||
| Fixed Assets | ₹1.4K Cr 38.7% | ₹998 Cr 2.0% | ₹978 Cr 36.2% | ₹718 Cr 0.3% | ₹720 Cr 5.3% | ₹684 Cr 8.6% | ₹630 Cr 44.8% | ₹435 Cr |
| CWIP | ₹129 Cr 56.4% | ₹296 Cr 60.0% | ₹185 Cr 150.0% | ₹74 Cr 155.2% | ₹29 Cr 7.4% | ₹27 Cr 3.8% | ₹26 Cr 160.0% | ₹10 Cr |
| Investments | ₹486 Cr 7.6% | ₹526 Cr 3.7% | ₹507 Cr 2882.4% | ₹17 Cr 750.0% | ₹2 Cr 33.3% | ₹3 Cr 57.1% | ₹7 Cr 250.0% | ₹2 Cr |
| Other Assets | ₹364 Cr 79.3% | ₹203 Cr 17.8% | ₹247 Cr 47.8% | ₹473 Cr 101.3% | ₹235 Cr 20.5% | ₹195 Cr 54.8% | ₹126 Cr 19.2% | ₹156 Cr |
| Total Assets | ₹2.4K Cr 16.8% | ₹2.0K Cr 5.5% | ₹1.9K Cr 49.6% | ₹1.3K Cr 29.9% | ₹986 Cr 8.5% | ₹909 Cr 15.2% | ₹789 Cr 30.8% | ₹603 Cr |
Values in ₹ Cr · Source: Screener.in
Cash Flow Statement
| Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|---|
| Operating CF | ₹268 Cr 0.4% | ₹267 Cr 132.2% | ₹115 Cr 34.7% | ₹176 Cr 28.5% | ₹137 Cr 11.4% | ₹123 Cr 66.2% | ₹74 Cr |
| Investing CF | ₹-442 Cr 11.1% | ₹-497 Cr 102.0% | ₹-246 Cr 161.7% | ₹-94 Cr 11.9% | ₹-84 Cr 71.5% | ₹-295 Cr 586.0% | ₹-43 Cr |
| Financing CF | ₹136 Cr 54.2% | ₹297 Cr 132.0% | ₹128 Cr 351.0% | ₹-51 Cr 259.4% | ₹32 Cr 82.6% | ₹184 Cr 675.0% | ₹-32 Cr |
| Net Cash Flow | ₹-38 Cr 157.6% | ₹66 Cr 2300.0% | ₹-3 Cr 109.7% | ₹31 Cr 63.5% | ₹85 Cr 608.3% | ₹12 Cr 1300.0% | ₹-1 Cr |
| Free Cash Flow | ₹-234 Cr 290.0% | ₹-60 Cr 306.9% | ₹29 Cr 71.0% | ₹100 Cr 117.4% | ₹46 Cr 139.0% | ₹-118 Cr 356.5% | ₹46 Cr |
Values in ₹ Cr · Source: Screener.in
Key Ratios History
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|---|
| Debtor Days | 18d 50.0% | 12d 36.8% | 19d 0.0% | 19d 35.7% | 14d 12.5% | 16d 54.3% | 35d |
| Inventory Days | 49d 28.9% | 38d 7.3% | 41d 6.8% | 44d 12.8% | 39d 18.8% | 48d 25.0% | 64d |
| Days Payable | 121d 22.2% | 99d 17.5% | 120d 26.8% | 164d 4.5% | 157d 27.6% | 217d 19.0% | 268d |
| Cash Conv. Cycle | -54d 10.2% | -49d 16.9% | -59d 41.6% | -101d 2.9% | -104d 31.6% | -152d 10.1% | -169d |
| Working Capital Days | -21d 10.5% | -19d 280.0% | -5d 79.2% | -24d 0.0% | -24d 242.9% | -7d 141.2% | 17d |
| ROCE | 15.0% 16.7% | 18.0% 18.2% | 22.0% 4.8% | 21.0% 23.5% | 17.0% 142.9% | 7.0% | — |
Source: Screener.in · Lower days = better efficiency
About Jupiter Life Line Hospitals Limited
Incorporated in 2007, Jupiter Life Line Hospitals Limited is a multi-specialty tertiary and quaternary healthcare provider in the Mumbai Metropolitan Area (MMR) and western region of India.[1]
HealthcareHealthcare Services